ACXP
Acurx Pharmaceuticals Sets New Standard with Breakthroughs in Antimicrobial Research
Acurx Pharmaceuticals, a leader in the development of novel antimicrobial agents, has made significant strides in the fourth quarter and full year 2025. The company's recent conference call provided a comprehensive overview of its achievements, highlighting key activities and milestones that have positioned Acurx as a forefront player